Replimune Group, Inc. Form 8-K Summary
Business context and reporting period
Replimune Group, Inc. filed a Form 8-K reporting events beginning June 1, 2023. The filing was signed and furnished on June 5, 2023. The company is a Delaware corporation headquartered in Woburn, Massachusetts, and its common stock trades on Nasdaq under the symbol REPL.
Material corporate and governance changes
- Veleka Peeples-Dyer was appointed to the Board of Directors effective June 1, 2023.
- The appointment filled the vacancy created after the Board increased its authorized size from nine to ten members on March 8, 2023.
- Ms. Peeples-Dyer was appointed to the Audit Committee, replacing Dieter Weinand, who stepped down from that committee.
- She will initially serve until the 2023 annual meeting of stockholders, where she is expected to stand for election.
- The Board determined that Ms. Peeples-Dyer is independent under applicable SEC and Nasdaq rules.
Compensation and related arrangements
- Annual cash retainers are $45,000 for Board service and $10,000 for Audit Committee service, each prorated from the appointment date.
- She received a nonqualified stock option covering 50,400 common shares, with an exercise price of $18.48, equal to the June 1, 2023 closing price.
- The option vests as to 25% of the shares on June 1, 2024, with the remainder vesting in approximately equal monthly installments over 24 months.
- The company entered into a customary indemnification agreement with Ms. Peeples-Dyer.
- The filing reports no other related-party transactions requiring disclosure under Item 404(a) of Regulation S-K and no arrangement or understanding regarding her selection.
Financial metrics, outlook, and risks
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, financial guidance, operating outlook, or quantitative risk disclosures. The filing text does not provide a clear value for any such metrics. The primary economic impact disclosed is the director compensation and equity award described above.
Most important facts to verify
- Confirm Ms. Peeples-Dyer’s election status at the company’s 2023 annual meeting.
- Verify the terms, vesting schedule, and accounting impact of the 50,400-share stock option.
- Assess any subsequent changes to Board or Audit Committee composition.
- Review the June 5, 2023 press release furnished as Exhibit 99.1 for additional biographical information.